<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04265625</url>
  </required_header>
  <id_info>
    <org_study_id>HULP5455</org_study_id>
    <nct_id>NCT04265625</nct_id>
  </id_info>
  <brief_title>Routine Use of FIBERoptic Bronchoscopic Guidance in Percutaneous TRACHeostomy</brief_title>
  <acronym>FIBERTRACH</acronym>
  <official_title>The Role of Routine Fiberoptic Bronchoscopic Guidance During Percutaneous Tracheostomy. A Prospective Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Investigación Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Investigación Hospital Universitario La Paz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tracheostomy is one of the most frequently performed techniques in intensive care units. For&#xD;
      some authors endoscopic guide as part of the percutaneous tracheostomy (PT) might reduces the&#xD;
      incidence of serious complications. However, for others, endoscopic guide increases the&#xD;
      procedure cost, increases airway pressure and PaCO2 and sometimes requires the presence of&#xD;
      another physician. International guidelines conclude that there is insufficient evidence to&#xD;
      support the routine use of bronchoscopy during PT in order to decrease the number of&#xD;
      complications. In addition the routine use of endoscopic guide is heterogeneous according the&#xD;
      results of six published nation surveys. Extensive randomized trials to compare PT with&#xD;
      endoscopic guide and without endoscopic guide are needed in order to clarify this&#xD;
      controversial issue. This constitutes the justification of this trial.&#xD;
&#xD;
      Hypothesis: Percutaneous tracheotomy performed under endoscopic guide decreases the incidence&#xD;
      of perioperative complications of the procedure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background&#xD;
&#xD;
      Tracheostomy is one of the most frequently performed techniques in intensive care units&#xD;
      (ICU). A few years after the description of the percutaneous dilatational tracheostomy (PDT),&#xD;
      endoscopic guide as part of the technique was performed in four patients. The authors&#xD;
      concluded that the endoscopic guide provided advantages to the realization of PDT. Other&#xD;
      authors have state that endoscopy, significantly reduces the incidence of serious&#xD;
      complications such as posterior tracheal tears, false passage, pneumothorax and subcutaneous&#xD;
      emphysema. However, currently endoscopic guide as part of the percutaneous tracheostomy is&#xD;
      controversial. Although for some authors its use reduces the number of complications, others&#xD;
      found that endoscopic guide increases the procedure cost, increases airway pressure and PaCO2&#xD;
      and sometimes requires the presence of another physician. Thus, some do not consider it&#xD;
      necessary when the physicians have enough experience with percutaneous tracheostomy.&#xD;
      International guidelines conclude that there is insufficient evidence to support the routine&#xD;
      use of bronchoscopy during percutaneous tracheostomy in order to decrease the number of&#xD;
      complications. In addition the routine use of endoscopic guide is heterogeneous according the&#xD;
      published surveys. Specifically, in Spain its use was the lowest of the six published nation&#xD;
      surveys. Extensive randomized trials to compare percutaneous tracheostomy with endoscopic&#xD;
      guide and without endoscopic guide are needed in order to clarify this controversial issue.&#xD;
      This constitutes the justification of this trial.&#xD;
&#xD;
      Hypothesis&#xD;
&#xD;
      Percutaneous tracheotomy performed under endoscopic guidance decreases the incidence of&#xD;
      perioperative complications of the procedure.&#xD;
&#xD;
      Main goal&#xD;
&#xD;
        1. - To assess the incidence of perioperative complications of percutaneous tracheotomy&#xD;
           under endoscopic guide versus blind percutaneous tracheotomy.&#xD;
&#xD;
        2. - To assess the ventilatory parameters during percutaneous tracheostomy with and without&#xD;
           endoscopic control.&#xD;
&#xD;
      Methodology&#xD;
&#xD;
      Prospective, multicenter randomized study. Patients admitted to the ICU who need tracheostomy&#xD;
      due to prolonged mechanical ventilation, who do not have neither contraindications to perform&#xD;
      the percutaneous technique nor contraindications to perform fibrobronchoscopy will be&#xD;
      randomized.&#xD;
&#xD;
      The percutaneous tracheostomy will be carried out with the single-step dilation method. For&#xD;
      its realization, the usual protocol will be followed.&#xD;
&#xD;
      The included patients will be randomized 1:1 (percutaneous tracheostomy with endoscopic guide&#xD;
      vs percutaneous tracheostomy without endoscopic guide). The randomization system will be by&#xD;
      closed envelope. A sample size of 221 patients in each branch has been calculated.&#xD;
&#xD;
      The percutaneous tracheostomy and fiberoptic bronchoscopy will be performed by staff with&#xD;
      experience with both procedures.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 7, 2019</start_date>
  <completion_date type="Anticipated">January 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with bleeding</measure>
    <time_frame>24 hours</time_frame>
    <description>Bleeding with haemodynamic derangement or needing surgical review or transfusion of packed red cells.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with hypoxemia</measure>
    <time_frame>During the procedure</time_frame>
    <description>Hypoxemia: Oxygen arterial saturation (SaO2) &lt; 85% during more than 90 seconds and/or arrhythmia or cardiac arrest related to hypoxemia.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients in whom a loss of airway has ocurred</measure>
    <time_frame>During the procedure</time_frame>
    <description>Loss of airway: Failure to be able to access the airway &gt; 30 seconds.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with atelectasis</measure>
    <time_frame>24 hours</time_frame>
    <description>Atelectasis: Total or partial lung collapse not present before the technique, evidenced at postoperative control.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with hypotension</measure>
    <time_frame>During the procedure</time_frame>
    <description>Hypotension requiring treatment with vasopressors or &gt;1000 ml of fluids during the procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with barotrauma</measure>
    <time_frame>24 hours</time_frame>
    <description>Barotrauma: Subcutaneous emphysema, mediastinal emphysema or pneumothorax related to the technique.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with posterior tracheal wall injury</measure>
    <time_frame>During the procedure</time_frame>
    <description>Posterior tracheal wall injury: Injury to membranous trachea from needle, guide or dilator.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients in whom false passage has ocurred</measure>
    <time_frame>During the procedure</time_frame>
    <description>False passage: Dilatation or insertion of the cannula out of the trachea lumen.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peak airway pressure</measure>
    <time_frame>During the procedure</time_frame>
    <description>Maximum peak airway pressure (cmH2O)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plateau pressure</measure>
    <time_frame>During the procedure</time_frame>
    <description>Maximum plateau pressure (cmH2O)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tidal volume</measure>
    <time_frame>During the procedure</time_frame>
    <description>Minimum tidal volume (mL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial Blood Gas</measure>
    <time_frame>2 hours</time_frame>
    <description>Arterial blood gase at the beginning and the end of the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen saturation (SaO2)</measure>
    <time_frame>During the procedure</time_frame>
    <description>Minimum arterial oxygen saturation (SaO2)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Mortality</measure>
    <time_frame>90 days</time_frame>
    <description>All-cause mortality at hospital discharge</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">442</enrollment>
  <condition>Tracheostomy Complication</condition>
  <arm_group>
    <arm_group_label>blind tracheotomy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no endoscopic guidance tracheotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>endoscopic guidance tracheotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>With endoscopic guidance tracheotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>endoscopic guidance</intervention_name>
    <description>Percutaneous tracheotomy performed by endoscopic guidance</description>
    <arm_group_label>endoscopic guidance tracheotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over 18 years old requiring tracheotomy due to prolonged mechanical&#xD;
             ventilation&#xD;
&#xD;
          -  That Family members or legal representatives have signed the information sheet and&#xD;
             informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with increased intracranial pressure according to intracranial pressure&#xD;
             monitoring or suspected.&#xD;
&#xD;
          -  Patients who have any absolute or relative contraindication for the percutaneous&#xD;
             tracheostomy realization&#xD;
&#xD;
          -  Patients with difficult airway&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose Manuel Añon, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario La Paz. IdiPAZ</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jose Manuel Añon, MD, PhD</last_name>
    <phone>+(34) 912071307</phone>
    <email>jmaelizalde@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Manuel Añon, MD,PhD</last_name>
      <phone>+(34) 912071307</phone>
      <email>jmaelizalde@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Infanta Leonor</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Covadonga Rodriguez, MD</last_name>
      <email>covarodriguezruiz@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Rey Juan Carlos</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel Perez-Marquez, MD</last_name>
      <email>mapemar@msn.com</email>
    </contact>
    <investigator>
      <last_name>Manuel Perez-Marquez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Añón JM, Arellano MS, Pérez-Márquez M, Díaz-Alvariño C, Márquez-Alonso JA, Rodríguez-Peláez J, Nanwani-Nanwani K, Martín-Pellicer A, Civantos B, López-Fernández A, Seises I, García-Nerín J, Figueira JC, Casero H, Vejo J, Agrifoglio A, Cachafeiro L, Díaz-Almirón M, Villar J. The role of routine FIBERoptic bronchoscopy monitoring during percutaneous dilatational TRACHeostomy (FIBERTRACH): a study protocol for a randomized, controlled clinical trial. Trials. 2021 Jun 29;22(1):423. doi: 10.1186/s13063-021-05370-x.</citation>
    <PMID>34187554</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 5, 2020</study_first_submitted>
  <study_first_submitted_qc>February 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2020</study_first_posted>
  <last_update_submitted>August 27, 2021</last_update_submitted>
  <last_update_submitted_qc>August 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto de Investigación Hospital Universitario La Paz</investigator_affiliation>
    <investigator_full_name>José Manuel Añón</investigator_full_name>
    <investigator_title>MD,PhD</investigator_title>
  </responsible_party>
  <keyword>Percutaneous tracheostomy, Fiberoptic bronchoscopic guidance</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

